1. Home
  2. SPRB vs MEGL Comparison

SPRB vs MEGL Comparison

Compare SPRB & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • MEGL
  • Stock Information
  • Founded
  • SPRB 2014
  • MEGL 2016
  • Country
  • SPRB United States
  • MEGL Hong Kong
  • Employees
  • SPRB N/A
  • MEGL N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • MEGL Finance: Consumer Services
  • Sector
  • SPRB Health Care
  • MEGL Finance
  • Exchange
  • SPRB Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • SPRB 5.5M
  • MEGL 4.8M
  • IPO Year
  • SPRB 2020
  • MEGL 2022
  • Fundamental
  • Price
  • SPRB $0.13
  • MEGL $1.27
  • Analyst Decision
  • SPRB Hold
  • MEGL
  • Analyst Count
  • SPRB 5
  • MEGL 0
  • Target Price
  • SPRB $1.75
  • MEGL N/A
  • AVG Volume (30 Days)
  • SPRB 2.6M
  • MEGL 24.6K
  • Earning Date
  • SPRB 04-15-2025
  • MEGL 05-06-2025
  • Dividend Yield
  • SPRB N/A
  • MEGL N/A
  • EPS Growth
  • SPRB N/A
  • MEGL N/A
  • EPS
  • SPRB N/A
  • MEGL N/A
  • Revenue
  • SPRB $4,911,000.00
  • MEGL $1,645,862.00
  • Revenue This Year
  • SPRB N/A
  • MEGL N/A
  • Revenue Next Year
  • SPRB $312.50
  • MEGL N/A
  • P/E Ratio
  • SPRB N/A
  • MEGL N/A
  • Revenue Growth
  • SPRB N/A
  • MEGL N/A
  • 52 Week Low
  • SPRB $0.12
  • MEGL $0.41
  • 52 Week High
  • SPRB $0.87
  • MEGL $3.06
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 23.23
  • MEGL 49.81
  • Support Level
  • SPRB $0.11
  • MEGL $1.12
  • Resistance Level
  • SPRB $0.14
  • MEGL $1.24
  • Average True Range (ATR)
  • SPRB 0.03
  • MEGL 0.13
  • MACD
  • SPRB -0.01
  • MEGL -0.00
  • Stochastic Oscillator
  • SPRB 11.12
  • MEGL 59.52

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: